Status:
COMPLETED
Italian Web-based Cross-sectional Survey on COVID-19
Lead Sponsor:
Institute of Biomedical Technologies-National Research Council, Italy
Collaborating Sponsors:
National Research Council, Institute of Clinical Physiology, Italy
Institute of Neuroscience-National Research Council
Conditions:
Covid19
SARS-CoV Infection
Eligibility:
All Genders
18+ years
Brief Summary
The outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that started in late December 2019 in the Hubei province of China caused millions of cases worldwide in just a few months, ...
Detailed Description
The COVID-19 pandemic is posing an unprecedented threat worldwide, which have been experiencing widespread transmission of the virus in the community for several weeks. During the epidemic peak, epid...
Eligibility Criteria
Inclusion
- age of \>=18 years;
- access to a mobile phone, computer, or tablet with internet connectivity;
- on-line consent to participate in the study.
Exclusion
- age of \<18 years;
- without access to a mobile phone, computer, or tablet with internet connectivity;
- not provide on-line consent to participate in the study.
Key Trial Info
Start Date :
April 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2021
Estimated Enrollment :
200000 Patients enrolled
Trial Details
Trial ID
NCT04471701
Start Date
April 13 2020
End Date
February 28 2021
Last Update
April 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Biomedical Technologies-National Research Council
Segrate, MI, Italy, 20090